Zidovudine (3'-azido-2',3'-dideoxythymidine [AZT]) inhibits human immunodef
iciency virus replication and delays progression of acquired immune deficie
ncy syndrome. We have recently found that, in muscle, AZT causes oxidative
damage to mitochondrial DNA (mtDNA) and other signs of mitochondrial oxidat
ive damage. The aim of this work was to test if AZT causes oxidative damage
to liver mtDNA. In our study, an experimental mouse model was used in whic
h mice were administered AZT (10 mg/kg body weight/d) in drinking water. Li
ver mtDNA of mice treated with AZT had 40% more of the oxidized, mutagenic
nucleoside, 8-ore-7,8-dihydroxy-2' deoxyguanosine (8-oxo-dG) than untreated
controls. This oxidative damage to mtDNA is caused by a significant increa
se (of over 240%) in peroxide production by liver mitochondria from AZT-tre
ated mice, which was prevented by dietary administration with vitamins C an
d E.